Results 191 to 199 of about 240,836 (199)

Andexanet Alfa Versus 4F-PCC for Direct Anticoagulation Reversal in Intracranial Hemorrhage: A Quality Improvement (QI) Analysis (P8-7.001)

Neurology
Audrey Huang, Jenny Yang, William Liu, Deepika Dilip, Nimrod Gozum, Gular Mammadli, Colleen Bond, Hasit Mehta, Stephan A. Mayer   +8 more
semanticscholar   +1 more source

Andexanet alfa in patients with spontaneous intracerebral hemorrhage related to apixaban or rivaroxaban

Neurological Sciences
M. Cappellari, A. Zini, Danilo Toni
semanticscholar   +1 more source

Anwendung von Andexanet alfa bei akutem Subduralhämatom

Anästhesie Nachrichten
Christian Schützner
semanticscholar   +1 more source

E-013 Comparative analysis of DOAC reversal agents in patients with intracranial hemorrhage for preventing bleed expansion after neurosurgical intervention: andexanet alfa vs. 4-factor PCC

SNIS 22nd annual meeting electronic poster abstracts
A. Rao, T. Hannah, S. Pathak, R. Ziechmann, K. Erkmen   +4 more
semanticscholar   +1 more source

Summary of opinion: Ondexxya,andexanet alfa

Case Medical Research, 2019
openaire   +2 more sources

Andexanet Alfa: A Recombinant Modified Human Factor Xa Protein for Drug Reversal of Rivaroxaban and Apixaban

Journal of Pharmacy Technology, 2019
exaly  

Andexanet alfa: expensive and harmful?

First10EM blog
openaire   +1 more source

Andexanet alfa: Antidot enttäuscht Erwartungen

ZI Zahnärztliche Implantologie
openaire   +1 more source

Idarucizumab- and andexanet alfa-related DIC

Reactions Weekly
openaire   +1 more source